Syros Pharmaceuticals, Inc. (SYRS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 11:09AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 135.51M |
| Enterprise Value | 58.06M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 14.45 |
| Price/Book (mrq) | 8.13 |
| Enterprise Value/Revenue | 5.84 |
| Enterprise Value/EBITDA | -0.37 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.78 |
| 52-Week Change 3 | 69.57% |
| S&P500 52-Week Change 3 | 22.64% |
| 52 Week High 3 | 8.1700 |
| 52 Week Low 3 | 2.0900 |
| 50-Day Moving Average 3 | 6.1557 |
| 200-Day Moving Average 3 | 4.7488 |
Share Statistics
| Avg Vol (3 month) 3 | 212.5k |
| Avg Vol (10 day) 3 | 182.69k |
| Shares Outstanding 5 | 26.73M |
| Implied Shares Outstanding 6 | 26.73M |
| Float 8 | 11.26M |
| % Held by Insiders 1 | 1.07% |
| % Held by Institutions 1 | 81.29% |
| Shares Short (Apr 15, 2024) 4 | 1.86M |
| Short Ratio (Apr 15, 2024) 4 | 7.23 |
| Short % of Float (Apr 15, 2024) 4 | 7.58% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 6.96% |
| Shares Short (prior month Mar 15, 2024) 4 | 1.74M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Sept 19, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -6,996.11% |
Management Effectiveness
| Return on Assets (ttm) | -38.32% |
| Return on Equity (ttm) | -227.95% |
Income Statement
| Revenue (ttm) | 9.94M |
| Revenue Per Share (ttm) | 0.35 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -124.25M |
| Net Income Avi to Common (ttm) | -164.57M |
| Diluted EPS (ttm) | -5.8100 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 139.53M |
| Total Cash Per Share (mrq) | 5.27 |
| Total Debt (mrq) | 62.08M |
| Total Debt/Equity (mrq) | 372.55% |
| Current Ratio (mrq) | 3.95 |
| Book Value Per Share (mrq) | 0.63 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -109.71M |
| Levered Free Cash Flow (ttm) | -66.66M |
© 2024 Yahoo. All rights reserved.